
Longevitytech.fund to resume fundraising in early September
Longevitytech.fund, a Czech vehicle investing in longevity-related technology companies globally, will aim to start raising an extra $10m from early September, according to co-founder and managing partner Petr Sramek.
The fund aims to hold a second close on $2-3m by February 2021 and to raise the remainder within a year, Sramek said. It could potentially raise more than $10m if the firm sees enough opportunities, he added.
The fund raised $1m from high-net-worth individuals in the Czech Republic earlier this year in a first closing, Sramek said, with the next rounds now opened up to international investors and institutional investors.
It has already attracted interest from new investors around the world, including several institutional investors, and some of the existing investors have expressed interest in re-upping for subsequent closes, Sramek added.
Longevitytech.fund currently has four companies in its portfolio and aims to invest in a total of up to 30 companies in the longevity space over the next two years, Sramek said. This includes companies in the biotech, ageing diagnostics, AI, agetech, regenerative therapies, wealthtech and fintech fields that are developing technologies related to improving and extending lifespans.
It will invest in pre-seed, seed and series-A rounds and plans to participate in follow-up rounds with some of its companies too, Sramek said. It largely co-invests in rounds with other investors.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater